|
Volumn 40, Issue 12, 2001, Pages 737-742
|
Sporotrichosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FLUCONAZOLE;
ITRACONAZOLE;
POTASSIUM DERIVATIVE;
POTASSIUM IODIDE;
POTASSIUM SPARING DIURETIC AGENT;
TERBINAFINE;
ANEMIA;
BACTERIAL METABOLISM;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CULTURE MEDIUM;
DIFFERENTIAL DIAGNOSIS;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DISEASE TRANSMISSION;
DOSE CALCULATION;
DRUG CHOICE;
DRUG COST;
DRUG EXCRETION;
DRUG TISSUE LEVEL;
EPIDEMIC;
FEVER;
FUNGUS ISOLATION;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
HYPERKALEMIA;
HYPERTHERMIC THERAPY;
HYPOTHYROIDISM;
IMMUNE DEFICIENCY;
IMMUNITY;
INCIDENCE;
INFECTION RISK;
KIDNEY DISEASE;
LEISHMANIASIS;
MICROBIOLOGICAL EXAMINATION;
MYCOBACTERIOSIS;
NONHUMAN;
PATHOPHYSIOLOGY;
RESTRICTION FRAGMENT LENGTH POLYMORPHISM;
SPOROTHRIX SCHENCKII;
SPOROTRICHOSIS;
VIRULENCE;
HUMANS;
SPOROTRICHOSIS;
|
EID: 0035686935
PISSN: 00119059
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-4362.2001.01295.x Document Type: Conference Paper |
Times cited : (66)
|
References (39)
|